Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of Ralinepag in Healthy Chinese Adult Subjects
- First Posted Date
- 2020-11-03
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Everstar Medicines (Shanghai) Limited
- Target Recruit Count
- 15
- Registration Number
- NCT04613999
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
News
No news found